Recall is for all lots of metformin hydrochloride extended-release tablets 500 mg from Apotex
FRIDAY, May 29, 2020 (HealthDay News) — A recall of the widely used diabetes drug metformin was announced by drug maker Apotex due to possible high levels of N-Nitrosodimethylamine (NDMA), which is believed to cause cancer in people.
The recall for all lots of metformin hydrochloride extended-release tablets 500 mg from Apotex comes after one lot tested by the U.S. Food and Drug Administration had higher NDMA levels than allowed by the FDA.
NDMA is an environmental contaminant that is found in water and foods, including meats, dairy products, and vegetables.
NDMA contamination triggered numerous recalls of widely used heart medicines last year.
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk 
GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
.jpg)
